The K562 cell line used in our experiments is a chronic myeloid leukemia model system, and as in many human cancers, dysregulation of the mTOR pathway is associated with disease progression (39). Here, MTOR is linked to chronic myelogenous leukemia, BCR-ABL1 positive.